Systems biology approaches to disease marker discovery

Disease Markers

Volumn 28, Issue 4, 2010, Pages 209-224

  Sharon, Donald ^a   Chen, Rui ^b   Snyder, Michael ^b  

^a YALE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autoimmune disease; cancer; disease markers; mass spectrometry; Next generation sequencing; protein microarray; Systems biology

Indexed keywords

ANTIBODY; DNA; MOLECULAR MARKER; PROTEIN; PROTEOME; TRANSCRIPTOME;

AUTOIMMUNE DISEASE; CLINICAL MEDICINE; DISEASE MARKER; DNA SEQUENCE; EARLY DIAGNOSIS; GENOME; GENOMICS; MASS SPECTROMETRY; METABOLOME; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SCREENING; SYSTEMS BIOLOGY; VIRUS INFECTION;

EID: 77954137469     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0707     Document Type: Review

References (121)

1. Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature 455 (2008), 1061-1068.
2. J.K. Adam, B. Odhav and K.D. Bhoola, Immune responses in cancer, Pharmacol Ther 99 (2003), 113-132.
3. M. Al Rwahnih, S. Daubert, D. Golino and A. Rowhani, Deep sequencing analysis ofRNAs from a grapevine showing Syrah decline symptoms reveals a multiple virus infection that includes a novel virus, Virology (2009).
4. M.S. Alhamdani, C. Schroder and J.D. Hoheisel, Oncoproteomic profiling with antibody microarrays, Genome Med 1 (2009), 68.
5. K.S. Anderson, N. Ramachandran, J. Wong, J.V. Raphael, E. Hainsworth, G. Demirkan, D. Cramer, D. Aronzon, F.S. Hodi, L. Harris, T. Logvinenko and J. LaBaer, Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer, J Proteome Res 7 (2008), 1490-1499.
6. R.K. Auerbach, G. Euskirchen, J. Rozowsky, N. Lamarre- Vincent, Z. Moqtaderi, P. Lefrancois, K. Struhl, M. Gerstein and M. Snyder, Mapping accessible chromatin regions using Sono-Seq, Proc Natl Acad Sci USA 106 (2009), 14926-14931.
7. I. Babel, R. Barderas, R. Diaz-Uriarte, J.L. Martinez- Torrecuadrada, M. Sanchez-Carbayo and J.I. Casal, Identi- fication of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays, Mol Cell Proteomics 8 (2009), 2382-2395.
8. A. Barski and K. Zhao, Genomic location analysis by ChIPSeq, J Cell Biochem 107 (2009), 11-18.
9. S. Bennett, Solexa Ltd, Pharmacogenomics 5 (2004), 433-438.
10. L.G. Biesecker, J.C. Mullikin, F.M. Facio, C. Turner, P.F. Cherukuri, R.W. Blakesley, G.G. Bouffard, P.S. Chines, P. Cruz, N.F. Hansen, J.K. Teer, B. Maskeri, A.C. Young, T.A. Manolio, A.F. Wilson, T. Finkel, P. Hwang, A. Arai, A.T. Remaley, V. Sachdev, R. Shamburek, R.O. Cannon and E.D. Green, The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine, Genome Res 19 (2009), 1665-1674.
11. B. Bloom, R.A. Cohen and G. Freeman, Summary health statistics for U.S. children: National Health Interview Survey, 2007, Vital Health Stat 10 (2009), 1-80.
12. I.L. Bontell, N. Hall, K.E. Ashelford, J.P. Dubey, J.P.Boyle, J. Lindh and J.E. Smith, Whole genome sequencing of a natural recombinant Toxoplasma gondii strain reveals chromosome sorting and local allelic variants, Genome Biol 10 (2009), R53.
13. A. Carlsson, C. Wingren, J. Ingvarsson, P. Ellmark, B. Baldertorp, M. Ferno, H. Olsson and C.A. Borrebaeck, Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays, Eur J Cancer 44 (2008), 472-480.
14. W.P. Carney, R. Neumann, A. Lipton, K. Leitzel, S. Ali and C.P. Price, Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer, Clin Chem 49 (2003), 1579-1598.
15. C. Chapman, A. Murray, J. Chakrabarti, A. Thorpe, C.Woolston, U. Sahin, A. Barnes and J. Robertson, Autoantibodies in breast cancer: their use as an aid to early diagnosis, Ann Oncol 18 (2007), 868-873.
16. M. Chatterjee, J. Wojciechowski and M.A. Tainsky, Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput, Methods Mol Biol 520 (2009), 21-38.
17. W.C. Cho, Contribution of oncoproteomics to cancer biomarker discovery, Mol Cancer 6 (2007), 25.
18. M.L. Cowan and J. Vera, Proteomics: advances in biomarker discovery, Expert Rev Proteomics 5 (2008), 21-23.
19. B.F. Cravatt, G.M. Simon and J.R. Yates, 3rd, The biological impact of mass-spectrometry-based proteomics, Nature 450 (2007), 991-1000.
20. R. Di Niro, S. D'Angelo, P. Secco, R. Marzari, C. Santoro and D. Sblattero, Profiling the autoantibody repertoire by screening phage-displayed human cDNA libraries, Methods Mol Biol 570 (2009), 353-369.
21. L. Ding, G. Getz, D.A. Wheeler, E.R. Mardis, M.D. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D.M. Muzny, M.B. Morgan, L. Fulton, R.S. Fulton, Q. Zhang, M.C.Wendl, M.S. Lawrence, D.E. Larson, K. Chen, D.J. Dooling, A. Sabo, A.C. Hawes, H. Shen, S.N. Jhangiani, L.R. Lewis, O. Hall, Y. Zhu, T. Mathew, Y. Ren, J. Yao, S.E. Scherer, K. Clerc, G.A. Metcalf, B. Ng, A. Milosavljevic, M.L. Gonzalez-Garay, J.R. Osborne, R. Meyer, X. Shi, Y. Tang, D.C. Koboldt, L. Lin, R. Abbott, T.L. Miner, C. Pohl, G. Fewell, C. Haipek, H. Schmidt, B.H. Dunford-Shore, A. Kraja, S.D. Crosby, C.S. Sawyer, T. Vickery, S. Sander, J. Robinson, W.Winckler, J. Baldwin, L.R. Chirieac, A. Dutt, T. Fennell, M. Hanna, B.E. Johnson, R.C. Onofrio, R.K. Thomas, G. Tonon, B.A. Weir, X. Zhao, L. Ziaugra, M.C. Zody, T. Giordano, M.B. Orringer, J.A. Roth, M.R. Spitz, Wistuba, II, B. Ozenberger, P.J. Good, A.C. Chang, D.G. Beer, M.A.Watson, M. Ladanyi, S. Broderick, A. Yoshizawa, W.D. Travis, W. Pao, M.A. Province, G.M.Weinstock, H.E. Varmus, S.B. Gabriel, E.S. Lander, R.A. Gibbs, M. Meyerson and R.K. Wilson, Somatic mutations affect key pathways in lung adenocarcinoma, Nature 455 (2008), 1069-1075.
22. J. Eid, A. Fehr, J. Gray, K. Luong, J. Lyle, G. Otto, P. Peluso, D. Rank, P. Baybayan, B. Bettman, A. Bibillo, K. Bjornson, B. Chaudhuri, F. Christians, R. Cicero, S. Clark, R. Dalal, A. Dewinter, J. Dixon, M. Foquet, A. Gaertner, P. Hardenbol, C. Heiner, K. Hester, D. Holden, G. Kearns, X. Kong, R. Kuse, Y. Lacroix, S. Lin, P. Lundquist, C. Ma, P. Marks, M. Maxham, D. Murphy, I. Park, T. Pham, M. Phillips, J. Roy, R. Sebra, G. Shen, J. Sorenson, A. Tomaney, K. Travers, M. Trulson, J. Vieceli, J.Wegener, D.Wu, A. Yang, D. Zaccarin, P. Zhao, F. Zhong, J. Korlach and S. Turner, Real-time DNA sequencing from single polymerase molecules, Science 323 (2009), 133-138.
23. J. Fasolo and M. Snyder, Protein microarrays, Methods Mol Biol 548 (2009), 209-222.
24. Z. Feng and Y. Yasui, Statistical considerations in combining biomarkers for disease classification, Dis Markers 20 (2004), 45-51.
25. L.C. Fry, K. Mönkemüller and P. Malfertheiner, Molecular markers of pancreatic cancer: development and clinical relevance, Langenbeck's archives of surgery/Deutsche Gesellschaft für Chirurgie 393 (2008), 883-890.
26. M. Gion, R. Mione, A.E. Leon and R. Dittadi, Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer, Clin Chem 45 (1999), 630-637.
27. P.G. Giresi, J. Kim, R.M. McDaniell, V.R. Iyer and J.D. Lieb, FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin, Genome Res 17 (2007), 877-885.
28. J.J. Graber and S. Dhib-Jalbut, Protective autoimmunity in the nervous system, Pharmacol Ther 121 (2009), 147-159.
29. R.T. Greenlee, M.B. Hill-Harmon, T. Murray and M. Thun, Cancer statistics, 2001, CA Cancer J Clin 51 (2001), 15-36.
30. J.L. Griffin and J.P. Shockcor, Metabolic profiles of cancer cells, Nat Rev Cancer 4 (2004), 551-561.
31. W.C. Hahn, I.F. Dunn, S.Y. Kim, A.C. Schinzel, R. Firestein, I. Guney and J.S. Boehm, Integrative genomic approaches to understanding cancer, Biochim Biophys Acta 1790 (2009), 478-484.
32. S.P. Halbert, J. Karsh and M. Anken, Studies on autoantibodies to deoxyribonucleic acid and deoxyribonucleoprotein with enzyme-immunoassay (ELISA), J Lab Clin Med 97 (1981), 97-111.
33. D.A. Hall, J. Ptacek and M. Snyder, Protein microarray technology, Mech Ageing Dev 128 (2007), 161-167.
34. J.A. Hanley and B.J. McNeil, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology 143 (1982), 29-36.
35. L.C. Harrison, J. Callaghan, J.C. Venter, C.M. Fraser and M.L. Kaliner, Atopy, autonomic function and beta-adrenergic receptor autoantibodies, Ciba Found Symp (1982), 248-262.
36. S.T. Holgate, Epithelium dysfunction in asthma, J Allergy Clin Immunol 120 (2007), 1233-1244; quiz 1245-11236
37. S.T. Holgate, Pathogenesis of asthma, Clin Exp Allergy 38 (2008), 872-897.
38. R.A. Holt and S.J. Jones, The new paradigm of flow cell sequencing, Genome Res 18 (2008), 839-846.
39. S. Horn, A. Lueking, D. Murphy, A. Staudt, C. Gutjahr, K. Schulte, A. Konig, M. Landsberger, H. Lehrach, S.B. Felix and D.J. Cahill, Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip, Proteomics 6 (2006), 605-613.
40. E. Huang, S.H. Cheng, H. Dressman, J. Pittman, M.H. Tsou, C.F. Horng, A. Bild, E.S. Iversen, M. Liao, C.M. Chen, M. West, J.R. Nevins and A.T. Huang, Gene expression predictors of breast cancer outcomes, Lancet 361 (2003), 1590-1596.
41. J. Huang, H. Zhu, S.J. Haggarty, D.R. Spring, H. Hwang, F. Jin, M. Snyder and S.L. Schreiber, Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips, Proc Natl Acad Sci USA 101 (2004), 16594-16599.
42. M.E. Hudson and M. Snyder, High-throughput methods of regulatory element discovery, Biotechniques 41 (2006), 673, 675, 677 passim.
43. M.E. Hudson, I. Pozdnyakova, K. Haines, G. Mor and M. Snyder, Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays, Proc Natl Acad Sci USA 104 (2007), 17494-17499.
44. A.S. Jang, J.S. Park, J.H. Lee, S.W. Park, D.J. Kim and C.S. Park, Autologous serum skin test for autoantibodies is associated with airway hyperresponsiveness in patients with asthma, Respiration 74 (2007), 293-296.
45. G. Jona and M. Snyder, Recent developments in analytical and functional protein microarrays, Curr Opin Mol Ther 5 (2003), 271-277.
46. Z. Kalnina, K. Silina, I. Meistere, P. Zayakin, A. Rivosh, A. Abols, M. Leja, O. Minenkova, D. Schadendorf and A. Line, Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients, J Immunol Methods 334 (2008), 37-50.
47. G. Kijanka and D. Murphy, Protein arrays as tools for serum autoantibody marker discovery in cancer, J Proteomics 72 (2009), 936-944.
48. K. Kim, I. Visintin, A.B. Alvero and G. Mor, Development and validation of a protein-based signature for the detection of ovarian cancer, Clin Lab Med 29 (2009), 47-55.
49. T. Kocher and G. Superti-Furga, Mass spectrometry-based functional proteomics: from molecular machines to protein networks, Nat Methods 4 (2007), 807-815.
50. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, G. Sauter and O.P. Kallioniemi, Tissue microarrays for highthroughput molecular profiling of tumor specimens, Nat Med 4 (1998), 844-847.
51. C. Kuk, V. Kulasingam, C.G. Gunawardana, C.R. Smith, I. Batruch and E.P. Diamandis, Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers, Mol Cell Proteomics 8 (2009), 661-669.
52. P. Lalle, M. De Latour, P. Rio and Y.J. Bignon, Detection of allelic losses on 17q12-q21 chromosomal region in benign lesions and malignant tumors occurring in a familial context, Oncogene 9 (1994), 437-442. (Pubitemid 24041522)
53. F. Le Naour, D.E. Misek, M.C. Krause, L. Deneux, T.J. Giordano, S. Scholl and S.M. Hanash, Proteomics-based identi- fication of RS/DJ-1 as a novel circulating tumor antigen in breast cancer, Clin Cancer Res 7 (2001), 3328-3335.
54. H.A. Lee, B.Kwon, G.Y. Hur, S.J. Choi, D.H.Nahm and H.S. Park, Isotype and IgG subclass distribution of autoantibody response to alpha-enolase protein in adult patients with severe asthma, Yonsei Med J 49 (2008), 923-930.
55. V.V. Levenson, Biomarkers for early detection of breast cancer: what, when, and where, Biochim Biophys Acta 1770 (2007), 847-856.
56. J.Z. Levin, M.F. Berger, X. Adiconis, P. Rogov, A. Melnikov, T. Fennell, C. Nusbaum, L.A. Garraway and A. Gnirke, Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts, Genome Biol 10 (2009), R115.
57. T.J. Ley, E.R. Mardis, L. Ding, B. Fulton, M.D. McLellan, K. Chen, D. Dooling, B.H. Dunford-Shore, S. McGrath, M. Hickenbotham, L. Cook, R. Abbott, D.E. Larson, D.C. Koboldt, C. Pohl, S. Smith, A. Hawkins, S. Abbott, D. Locke, L.W. Hillier, T. Miner, L. Fulton, V. Magrini, T. Wylie, J. Glasscock, J. Conyers, N. Sander, X. Shi, J.R. Osborne, P. Minx, D. Gordon, A. Chinwalla, Y. Zhao, R.E. Ries, J.E. Payton, P. Westervelt, M.H. Tomasson, M. Watson, J. Baty, J. Ivanovich, S. Heath, W.D. Shannon, R. Nagarajan, M.J. Walter, D.C. Link, T.A. Graubert, J.F. DiPersio and R.K. Wilson, DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome, Nature 456 (2008), 66-72.
58. B. Leyland-Jones, Trastuzumab: hopes and realities, Lancet Oncol 3 (2002), 137-144.
59. Q.Z. Li, J. Zhou, A.E.Wandstrat, F. Carr-Johnson, V. Branch, D.R. Karp, C. Mohan, E.K.Wakeland and N.J. Olsen, Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes, Clin Exp Immunol 147 (2007), 60-70.
60. P. Lin, Plasma cell myeloma, Hematol Oncol Clin North Am 23 (2009), 709-727.
61. A. Lueking, O. Huber, C. Wirths, K. Schulte, K.M. Stieler, U. Blume-Peytavi, A. Kowald, K. Hensel-Wiegel, R. Tauber, H. Lehrach, H.E. Meyer and D.J. Cahill, Profiling of alopecia areata autoantigens based on protein microarray technology, Mol Cell Proteomics 4 (2005), 1382-1390.
62. E.R. Mardis and R.K. Wilson, Cancer genome sequencing: a review, Hum Mol Genet 18 (2009), R163-168.
63. M. Margulies, M. Egholm,W.E. Altman, S. Attiya, J.S. Bader, L.A. Bemben, J. Berka, M.S. Braverman, Y.J. Chen, Z. Chen, S.B. Dewell, L. Du, J.M. Fierro, X.V. Gomes, B.C. Godwin, W. He, S. Helgesen, C.H. Ho, G.P. Irzyk, S.C. Jando, M.L. Alenquer, T.P. Jarvie, K.B. Jirage, J.B. Kim, J.R. Knight, J.R. Lanza, J.H. Leamon, S.M. Lefkowitz, M. Lei, J. Li, K.L. Lohman, H. Lu, V.B. Makhijani, K.E. McDade, M.P. McKenna, E.W. Myers, E. Nickerson, J.R. Nobile, R. Plant, B.P. Puc, M.T. Ronan, G.T. Roth, G.J. Sarkis, J.F. Simons, J.W. Simpson, M. Srinivasan, K.R. Tartaro, A. Tomasz, K.A. Vogt, G.A. Volkmer, S.H. Wang, Y. Wang, M.P. Weiner, P. Yu, R.F. Begley and J.M. Rothberg, Genome sequencing in microfabricated high-density picolitre reactors, Nature 437 (2005), 376-380.
64. G.A. Michaud, M. Salcius, F. Zhou, R. Bangham, J. Bonin, H. Guo, M. Snyder, P.F. Predki and B.I. Schweitzer, Analyzing antibody specificity with whole proteome microarrays, Nat Biotechnol 21 (2003), 1509-1512.
65. G.A. Michaud, M. Salcius, F. Zhou, V.V. Papov, J. Merkel, M. Murtha, P. Predki and B. Schweitzer, Applications of protein arrays for small molecule drug discovery and characterization, Biotechnol Genet Eng Rev 22 (2006), 197-211.
66. G. Mor, I. Visintin, Y. Lai, H. Zhao, P. Schwartz, T. Rutherford, L. Yue, P. Bray-Ward and D.C. Ward, Serum protein markers for early detection of ovarian cancer, Proc Natl Acad Sci USA 102 (2005), 7677-7682.
67. U. Nagalakshmi, Z. Wang, K. Waern, C. Shou, D. Raha, M. Gerstein and M. Snyder, The transcriptional landscape of the yeast genome defined by RNA sequencing, Science 320 (2008), 1344-1349.
68. D.H. Nahm, Y.E. Lee, E.J. Yim, H.S. Park, H. Yim, Y. Kang and J.K. Kim, Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma, Am J Respir Crit Care Med 165 (2002), 1536-1539.
69. S. Nakamura, C.S. Yang, N. Sakon, M. Ueda, T. Tougan, A. Yamashita, N. Goto, K. Takahashi, T. Yasunaga, K. Ikuta, T. Mizutani, Y. Okamoto, M. Tagami, R. Morita, N. Maeda, J. Kawai, Y. Hayashizaki, Y. Nagai, T. Horii, T. Iida and T. Nakaya, Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach, PLoS ONE 4 (2009), e4219.
70. S. Natter, S. Seiberler, P. Hufnagl, B.R. Binder, A.M. Hirschl, J. Ring, D. Abeck, T. Schmidt, P.Valent and R.Valenta, Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients, FASEB J 12 (1998), 1559-1569.
71. F. Ozsolak, A.R. Platt, D.R. Jones, J.G. Reifenberger, L.E. Sass, P. McInerney, J.F. Thompson, J. Bowers, M. Jarosz and P.M. Milos, Direct RNA sequencing, Nature 461 (2009), 814-818.
72. G. Palacios, J. Druce, L. Du, T. Tran, C. Birch, T. Briese, S. Conlan, P.L. Quan, J. Hui, J. Marshall, J.F. Simons, M. Egholm, C.D. Paddock, W.J. Shieh, C.S. Goldsmith, S.R. Zaki, M. Catton and W.I. Lipkin, A new arenavirus in a cluster of fatal transplant-associated diseases, N Engl J Med 358 (2008), 991-998.
73. T. Palomero and A.A. Ferrando, Genomic tools for dissecting oncogenic transcriptional networks in human leukemia, Leukemia 23 (2009), 1236-1242.
74. T.H. Patwa, Y. Wang, D.M. Simeone and D.M. Lubman, Enhanced detection of autoantibodies on protein microarrays using a modified protein digestion technique, J Proteome Res 7 (2008), 2553-2561.
75. S.P. Peters, G. Ferguson, Y. Deniz and C. Reisner, Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment, Respir Med 100 (2006), 1139-1151.
76. J. Pittman, E. Huang, H. Dressman, C.F. Horng, S.H. Cheng, M.H. Tsou, C.M. Chen, A. Bild, E.S. Iversen, A.T. Huang, J.R. Nevins and M. West, Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes, Proc Natl Acad Sci USA 101 (2004), 8431-8436.
77. A.E. Platts, S.J. Land, L. Chen, G.P. Page, P. Rasouli, L. Wang, X. Lu and D.M. Ruden, Massively parallel resequencing of the isogenic Drosophila melanogaster strain w(1118); iso-2; iso-3 identifies hotspots for mutations in sensory perception genes, Fly (Austin) 3 (2009), 192-203.
78. M. Plebani, M. Pittoni, M. Celadin, D. Bernardi and M.M. Mion, Recent advances in diagnostic technologies for autoimmune diseases, Autoimmun Rev 8 (2009), 238-243.
79. J. Ptacek, G. Devgan, G. Michaud, H. Zhu, X. Zhu, J. Fasolo, H. Guo, G. Jona, A. Breitkreutz, R. Sopko, R.R. McCartney, M.C. Schmidt, N. Rachidi, S.J. Lee, A.S. Mah, L. Meng, M.J. Stark, D.F. Stern, C. De Virgilio, M. Tyers, B. Andrews, M. Gerstein, B. Schweitzer, P.F. Predki and M. Snyder, Global analysis of protein phosphorylation in yeast, Nature 438 (2005), 679-684. (Pubitemid 41740579)
80. J. Qiu, G. Choi, L. Li, H. Wang, S.J. Pitteri, S.R. Pereira- Faca, A.L. Krasnoselsky, T.W. Randolph, G.S. Omenn, C. Edelstein, M.J. Barnett, M.D. Thornquist, G.E. Goodman, D.E. Brenner, Z. Feng and S.M. Hanash, Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera, J Clin Oncol 26 (2008), 5060-5066.
81. J. Qiu and S. Hanash, Autoantibody profiling for cancer detection, Clin Lab Med 29 (2009), 31-46.
82. F.J. Quintana, M.F. Farez, V. Viglietta, A.H. Iglesias, Y. Merbl, G. Izquierdo, M. Lucas, A.S. Basso, S.J. Khoury, C.F. Lucchinetti, I.R. Cohen and H.L. Weiner, Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis, Proc Natl Acad Sci USA 105 (2008), 18889-18894.
83. M.S. Raab, K. Podar, I. Breitkreutz, P.G. Richardson and K.C. Anderson, Multiple myeloma, Lancet 374 (2009), 324-339.
84. S.V. Rajkumar, A. Dispenzieri and R.A. Kyle, Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment, Mayo Clin Proc 81 (2006), 693-703.
85. R. Ralhan, L.V. Desouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur and K.W. Siu, Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry, Mol Cell Proteomics 7 (2008), 1162-1173.
86. N. Ramachandran, J.V. Raphael, E. Hainsworth, G. Demirkan, M.G. Fuentes, A. Rolfs, Y. Hu and J. LaBaer, Next-generation high-density self-assembling functional protein arrays, Nat Methods 5 (2008), 535-538.
87. M. Reuschenbach, M. von Knebel Doeberitz and N. Wentzensen, A systematic review of humoral immune responses against tumor antigens, Cancer Immunol Immunother 58 (2009), 1535-1544.
88. M. Rottem and Y. Shoenfeld, Asthma as a paradigm for autoimmune disease, Int Arch Allergy Immunol 132 (2003), 210-214.
89. A.H. Rowe, Insulin Treatment of Diabetes Mellitus, Cal State J Med 21 (1923), 204-208.
90. M.J. Scanlan, I. Gout, C.M. Gordon, B. Williamson, E. Stockert, A.O. Gure, D. Jager, Y.T. Chen, A. Mackay, M.J. O'Hare and L.J. Old, Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression, Cancer Immun 1 (2001), 4.
91. P.E. Schwartz, Current diagnosis and treatment modalities for ovarian cancer, Cancer Treat Res 107 (2002), 99-118.
92. N.J. Serkova and K. Glunde, Metabolomics of cancer, Methods Mol Biol 520 (2009), 273-295.
93. S.P. Shah, M. Kobel, J. Senz, R.D. Morin, B.A. Clarke, K.C. Wiegand, G. Leung, A. Zayed, E. Mehl, S.E. Kalloger, M. Sun, R. Giuliany, E. Yorida, S. Jones, R. Varhol, K.D. Swenerton, D. Miller, P.B. Clement, C. Crane, J. Madore, D. Provencher, P. Leung, A. DeFazio, J. Khattra, G. Turashvili, Y. Zhao, T. Zeng, J.N. Glover, B.Vanderhyden, C. Zhao, C.A. Parkinson, M. Jimenez-Linan, D.D. Bowtell, A.M. Mes- Masson, J.D. Brenton, S.A. Aparicio, N. Boyd, M. Hirst, C.B. Gilks, M. Marra and D.G. Huntsman, Mutation of FOXL2 in granulosa-cell tumors of the ovary, N Engl J Med 360 (2009), 2719-2729.
94. J. Shen, M.D. Person, J. Zhu, J.L. Abbruzzese and D. Li, Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry, Cancer Res 64 (2004), 9018-9026.
95. B.O. Shum, M.S. Rolph and W.A. Sewell, Mechanisms in allergic airway inflammation - lessons from studies in the mouse, Expert Rev Mol Med 10 (2008), e15.
96. M.G. Smith, T.A. Gianoulis, S. Pukatzki, J.J. Mekalanos, L.N. Ornston, M. Gerstein and M. Snyder, New insights into Acinetobacter baumannii pathogenesis revealed by highdensity pyrosequencing and transposon mutagenesis, Genes Dev 21 (2007), 601-614.
97. K. Somers, C. Govarts, P. Stinissen and V. Somers, Multiplexing approaches for autoantibody profiling in multiple sclerosis, Autoimmun Rev 8 (2009), 573-579.
98. Q. Song, G. Liu, S. Hu, Y. Zhang, Y. Tao, Y. Han, H. Zeng, W. Huang, F. Li, P. Chen, J. Zhu, C. Hu, S. Zhang, Y. Li, H. Zhu and L. Wu, Novel Autoimmune Hepatitis-Specific Autoantigens Identified Using Protein Microarray Technology, J Proteome Res (2009).
99. K. Sorber, C. Chiu, D. Webster, M. Dimon, J.G. Ruby, A. Hekele and J.L. DeRisi, The long march: a sample preparation technique that enhances contig length and coverage by high-throughput short-read sequencing, PLoS ONE 3 (2008), e3495.
100. R.S. Sun, X.H. Chen, R.Q. Liu, T.M. Cheng, X.Z. Ran and T. Yang, Autoantibodies to the high-affinity IgE receptor in patients with asthma, Asian Pac J Allergy Immunol 26 (2008), 19-22.
101. R.S. Sun, X.H. Chen, J.F. Sui, R.Q. Liu, T.M. Cheng, X.Z. Ran and T. Yang, Detecting anti-FcepsilonRI autoantibodies in patients with asthma by flow cytometry, J Int Med Res 36 (2008), 1214-1219.
102. B. Tomaino, P. Cappello, M. Capello, C. Fredolini, A. Ponzetto, A. Novarino, L. Ciuffreda, O. Bertetto, C. De Angelis, E. Gaia, P. Salacone, M. Milella, P. Nistic̀o, M. Alessio, R. Chiarle, M.G. Giuffrida, M. Giovarelli and F. Novelli, Autoantibody signature in human ductal pancreatic adenocarci- noma, J Proteome Res 6 (2007), 4025-4031.
103. G.E. Trivers, V.M. De Benedetti, H.L. Cawley, G. Caron, A.M. Harrington, W.P. Bennett, J.R. Jett, T.V. Colby, H. Tazelaar, P. Pairolero, R.D. Miller and C.C. Harris, Antip53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer, Clin Cancer Res 2 (1996), 1767-1775.
104. R. Valenta, S. Natter, S. Seiberler, S. Wichlas, D. Maurer, M. Hess, M. Pavelka, M. Grote, F. Ferreira, Z. Szepfalusi, P. Valent and G. Stingl, Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients, J Invest Dermatol 111 (1998), 1178-1183.
105. R. Valenta, S. Seiberler, S. Natter, V. Mahler, R. Mossabeb, J. Ring and G. Stingl, Autoallergy: a pathogenetic factor in atopic dermatitis?, J Allergy Clin Immunol 105 (2000), 432-437.
106. L.J. van 't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T.Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards and S.H. Friend, Gene expression profiling predicts clinical outcome of breast cancer, Nature 415 (2002), 530-536.
107. M.Vejtorp, M. Hoier-Madsen and P. Halberg, Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor, Scand J Rheumatol 8 (1979), 65-70.
108. J.C. Venter, C.M. Fraser and L.C. Harrison, Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma, Science 207 (1980), 1361-1363.
109. C. Vicentini, C. Festuccia, G.L. Gravina, A. Angelucci, A. Marronaro and M. Bologna, Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures, J Cancer Res Clin Oncol 129 (2003), 165-174.
110. I. Visintin, Z. Feng, G. Longton, D.C. Ward, A.B. Alvero, Y. Lai, J. Tenthorey, A. Leiser, R. Flores-Saaib, H. Yu, M. Azori, T. Rutherford, P.E. Schwartz and G. Mor, Diagnostic markers for early detection of ovarian cancer, Clin Cancer Res 14 (2008), 1065-1072.
111. P. Wang, J.R. Whiteaker and A.G. Paulovich, The evolving role of mass spectrometry in cancer biomarker discovery, Cancer Biol Ther 8 (2009), 1083-1094.
112. Z. Wang, M. Gerstein and M. Snyder, RNA-Seq: a revolutionary tool for transcriptomics, Nat Rev Genet (2008).
113. Z.Wang, L. Jiang, C. Huang, Z. Li, L. Chen, L. Gou, P. Chen, A. Tong, M. Tang, F. Gao, J. Shen, Y. Zhang, J. Bai, M. Zhou, D. Miao and Q. Chen, Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma, Mol Cell Proteomics 7 (2008), 1639-1650.
114. M.R.Warrier and G.K. Hershey, Asthma genetics: personalizing medicine, J Asthma 45 (2008), 257-264.
115. M.P. Washburn, D. Wolters and J.R. Yates, 3rd, Large-scale analysis of the yeast proteome by multidimensional protein identification technology, Nat Biotechnol 19 (2001), 242-247. (Pubitemid 32220565)
116. L. Wu and D.K. Han, Overcoming the dynamic range problem in mass spectrometry-based shotgun proteomics, Expert Rev Proteomics 3 (2006), 611-619.
117. L. Zhong, K. Ge, J.C. Zu, L.H. Zhao, W.K. Shen, J.F.Wang, X.G. Zhang, X. Gao,W. Hu, Y. Yen and K.H. Kernstine, Autoantibodies as potential biomarkers for breast cancer, Breast Cancer Res 10 (2008), R40.
118. H. Zhu, M. Bilgin, R. Bangham, D. Hall, A. Casamayor, P. Bertone, N. Lan, R. Jansen, S. Bidlingmaier, T. Houfek, T. Mitchell, P. Miller, R.A. Dean, M. Gerstein and M. Snyder, Global analysis of protein activities using proteome chips, Science 293 (2001), 2101-2105.
119. H. Zhu, S. Hu, G. Jona, X. Zhu, N. Kreiswirth, B.M.Willey, T. Mazzulli, G. Liu, Q. Song, P. Chen, M. Cameron, A. Tyler, J.Wang, J.Wen,W. Chen, S. Compton and M. Snyder, Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray, Proc Natl Acad Sci USA 103 (2006), 4011-4016.
120. X. Zhu, M. Gerstein and M. Snyder, ProCAT: a data analysis approach for protein microarrays, Genome Biol 7 (2006), R110.
121. B. Zweiman, Asthma and autoimmunity: is there a connection? Curr Allergy Asthma Rep 7 (2007), 157-158.